These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 18181081

  • 1. Cardiovascular disease risk factors in polycystic ovary syndrome.
    Dokras A.
    Semin Reprod Med; 2008 Jan; 26(1):39-44. PubMed ID: 18181081
    [Abstract] [Full Text] [Related]

  • 2. Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts?
    Chang AY, Wild RA.
    Semin Reprod Med; 2009 Jul; 27(4):299-305. PubMed ID: 19530063
    [Abstract] [Full Text] [Related]

  • 3. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F, Vuolo L, Palomba S, Lombardi G, Colao A.
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [Abstract] [Full Text] [Related]

  • 4. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.
    Cheung LP, Ma RC, Lam PM, Lok IH, Haines CJ, So WY, Tong PC, Cockram CS, Chow CC, Goggins WB.
    Hum Reprod; 2008 Jun; 23(6):1431-8. PubMed ID: 18359783
    [Abstract] [Full Text] [Related]

  • 5. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
    Bethea SW, Nestler JE.
    Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome.
    Vural B, Caliskan E, Turkoz E, Kilic T, Demirci A.
    Hum Reprod; 2005 Sep; 20(9):2409-13. PubMed ID: 15919774
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular health in women with polycystic ovary syndrome.
    Sukalich S, Guzick D.
    Semin Reprod Med; 2003 Aug; 21(3):309-15. PubMed ID: 14593554
    [Abstract] [Full Text] [Related]

  • 8. Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence.
    Talbott EO, Zborowskii JV, Boudraux MY.
    Minerva Ginecol; 2004 Feb; 56(1):27-39. PubMed ID: 14973408
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular risk in women with polycystic ovary syndrome.
    Cho LW, Atkin SL.
    Minerva Endocrinol; 2007 Dec; 32(4):263-73. PubMed ID: 18091663
    [Abstract] [Full Text] [Related]

  • 10. Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome.
    Luque-Ramírez M, Mendieta-Azcona C, Alvarez-Blasco F, Escobar-Morreale HF.
    Hum Reprod; 2007 Dec; 22(12):3197-203. PubMed ID: 17933750
    [Abstract] [Full Text] [Related]

  • 11. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis.
    Shroff R, Kerchner A, Maifeld M, Van Beek EJ, Jagasia D, Dokras A.
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4609-14. PubMed ID: 17848406
    [Abstract] [Full Text] [Related]

  • 12. Polycystic ovary syndrome and cardiovascular disease.
    Loverro G.
    Minerva Endocrinol; 2004 Sep; 29(3):129-38. PubMed ID: 15282445
    [Abstract] [Full Text] [Related]

  • 13. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R, Rossinelli N, Keller U, Tirri BF, De Geyter C, Ruiz J, Kränzlin M, Puder JJ.
    Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C.
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [Abstract] [Full Text] [Related]

  • 15. [Prevalence of metabolic disorders among family members of patients with polycystic ovary syndrome].
    Benítez R, Sir-Petermann T, Palomino A, Angel B, Maliqueo M, Pérez F, Calvillán M.
    Rev Med Chil; 2001 Jul; 129(7):707-12. PubMed ID: 11552437
    [Abstract] [Full Text] [Related]

  • 16. Long-term consequences of polycystic ovary syndrome on cardiovascular risk.
    Rizzo M, Berneis K, Spinas G, Rini GB, Carmina E.
    Fertil Steril; 2009 Apr; 91(4 Suppl):1563-7. PubMed ID: 18976752
    [Abstract] [Full Text] [Related]

  • 17. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
    Meyer C, McGrath BP, Teede HJ.
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
    [Abstract] [Full Text] [Related]

  • 18. Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women.
    Alexander CJ, Tangchitnob EP, Lepor NE.
    Rev Cardiovasc Med; 2009 Oct; 10(2):83-90. PubMed ID: 19593320
    [Abstract] [Full Text] [Related]

  • 19. Thrombin-activatable fibrinolysis inhibitor and cardiovascular risk factors in polycystic ovary syndrome.
    Erdoğan M, Karadeniz M, Alper GE, Tamsel S, Uluer H, Cağlayan O, Saygili F, Yilmaz C.
    Exp Clin Endocrinol Diabetes; 2008 Mar; 116(3):143-7. PubMed ID: 18350479
    [Abstract] [Full Text] [Related]

  • 20. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.
    Zwirska-Korczala K, Sodowski K, Konturek SJ, Kuka D, Kukla M, Brzozowski T, Cnota W, Woźniak-Grygiel E, Jaworek J, Bułdak R, Rybus-Kalinowska B, Fryczowski M.
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.